Award
National Heart, Lung, and Blood Institute 5U24HL151457-05
2/2 Kids MoD PAH Trial: Mono- vs. Duo-Therapy for Pediatric Pulmonary Arterial Hypertension-DCC
Recipient
National Heart Lung and Blood Institute (NHLBI)
Award Amount
$465,712.00
Ceiling
$465,712.00
Awarded
March 03, 2026
Identifier
5U24HL151457-05
Award for a clinical trial project focused on pediatric pulmonary arterial hypertension, aiming to improve treatment strategies and care for affected children.
Description
This project addresses critical gaps in pediatric pulmonary arterial hypertension (PAH) by testing a clinical strategy with potential for broad impact, including defining study endpoints and surrogates to facilitate evidence-based decision-making and enhance care for children with PAH.